Simon van der Pol

All papers authored by Simon van der Pol

This paper was not found in any repository, but could be made available legally by the author.

2024 Simon van der Pol

, Maarten J. Postma

, Cornelis Boersma

Antivirals to prepare for surges in influenza cases: an economic evaluation of baloxavir marboxil for the Netherlands

Upload

2021 Simon van der Pol

, Paula Rojas Garcia

, Maarten J. Postma

, Fernando Antoñanzas Villar

, Antoinette D. I. van Asselt

Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review

Upload

Simon van der Pol

, Jan-Willem H. Dik, Corinna Glasner, Maarten J. Postma, Bhanu Sinha, Alex W. Friedrich

The tripartite insurance model (TIM): a financial incentive to prevent outbreaks of infections due to multidrug-resistant microorganisms in hospitals

Upload

Marije E. Hagendijk

, Simon van der Schans, Cornelis Boersma

, Maarten J. Postma, Simon van der Pol

Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands

Upload

This paper is made freely available by the publisher.

Paula Rojas García

, Simon van der Pol

, Antoinette D. I. van Asselt, Maarten Postma, Roberto Rodríguez-Ibeas, Carmelo A. Juárez-Castelló

, Marino González

, Fernando Antoñanzas

Efficiency of Diagnostic Testing for Helicobacter pylori Infections—A Systematic Review

Download from doi.org

2020 Simon van der Schans

, Gert T. Vondeling, Qi Cao, Simon van der Pol

, Sipke Visser, Maarten J. Postma

, Mark H. Rozenbaum

The impact of patent expiry on drug prices: insights from the Dutch market

Download from doi.org

Simon van der Pol

, Lisa A. de Jong, Pepijn Vemer, Danielle E. M. C. Jansen, Maarten J. Postma

Author's Reply

Upload

Simon van der Pol

, Maarten J. Postma, Danielle E. M. C. Jansen

School health in Europe: a review of workforce expenditure across five countries

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Simon van der Pol

, Tanja Fens

, Janwillem Kocks, Maarten Postma, Job van Boven

Goed volgen nieuwe COPD-richtlijn maakt kostenbesparing mogelijk

Upload

2019 Simon van der Pol

, Paula Rojas, Carmello Juarez-Castello, Antoinette van Asselt, Fernando Antonanzas, Maarten Postma

Health-economic modelling of infectious disease diagnostics: current approaches and future opportunities

Upload

Tanja Fens

, Simon van der Pol

, Janwillem W. H. Kocks, Maarten J. Postma, Job F. M. van Boven

Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease: ISPOR's Guidance on Budget Impact in Practice

Upload

Simon van der Pol

, Lisa A. de Jong, Pepijn Vemer, Danielle E. M. C. Jansen, Maarten J. Postma

Cost-Effectiveness of Sacubitril/Valsartan in Germany: An Application of the Efficiency Frontier

Upload

Simon van der Pol

, Maartje S. Jacobs, Karina Meijer, Margriet G. Piersma-Wichers, Robert G. Tieleman, Maarten J. Postma, Marinus van Hulst

Perioperative bridging of vitamin K antagonist treatment in patients with atrial fibrillation: only a very small group of patients benefits

Upload

2018 Simon van der Pol

Cost-Effectiveness of Sacubitril/Valsartan in Germany: Applying the Efficiency Threshold

Upload

S. van der Pol

, Mj Postma, Demc Jansen

Costs and Cost Effectiveness of School Health Systems

Upload

Simon van der Pol

, Maartje Jacobs, Karina Meijer, Margriet G. Piersma Wichers, Tieleman Rg, Maarten Postma, Marinus van Hulst

To Bridge or Not to Bridge

Upload

2017 Simon van der Pol

, Fabian Degener, Maarten J. Postma, Pepijn Vemer

An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Simon van der Pol